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IntroductIon
The field of pediatric otolaryngology has 
undergone significant changes over the past 
two decades. These changes have resulted in 
new areas of investigations and challenges. 
This article will summarize some of the 
more recent advances and challenges fac-
ing this field. Specific focus of this grand 
challenge will include: (1) Role of biofilms 
in infectious diseases in otolaryngology, 
(2) tissue engineering in pediatric airway 
reconstructive surgery, (3) minimally inva-
sive surgical techniques, and (4) advances in 
molecular biology of sensorineural hearing 
loss (SNHL).
BIofIlms as unIque model for 
chronIc and recurrent InfectIons 
In otolaryngology
The burden of infectious diseases in several 
clinical problems encountered in pediatric 
otolaryngology is quite extensive. Though 
previously not well defined, the evidence 
to support biofilms as a pathophysiologic 
model in otolaryngology has increased 
remarkably over the last decade. Biofilms 
have been implicated in the pathogenesis 
of otitis media (OM), chronic rhinosinusi-
tis (CRS), chronic tonsillitis, cholesteatoma, 
recurrent tracheitis, and cochlear implant 
infections.
The initial implication of biofilm phe-
notypes in acute OM (AOM) and OM with 
effusion (OME) was postulated following 
the observation fact that many patients with 
middle ear effusion were culture negative. 
Furthermore, several studies demonstrated 
that a significant portion of these effusions 
did in fact have bacterial mRNA or were 
PCR positive for bacterial DNA (1). These 
observations were paramount and sug-
gested that biofilms may play a role in OM. 
Further research demonstrated that the 
three predominant causative agents for OM, 
Streptococcus pneumoniae, Haemophilus 
influenzae, and Moraxella catarrhalis, form 
biofilms in both in vitro and in vivo settings 
(2). This evidence, along with several inves-
tigations, would suggest that the primary 
pathogens for OM are capable of forming 
biofilms (2, 3). This is an important obser-
vation as bacteria in biofilm phenotypes can 
survive at antibiotic concentrations >2000 
times the minimum inhibitory concentra-
tion (MIC) (4, 5).
The clinical importance of biofilm for-
mation by known middle ear pathogens 
(MEPs) was also demonstrated by an ani-
mal model that closely parallels the human 
disease state. The model utilized superinfec-
tion of Influenza A and S. pneumoniae inoc-
ulation via the nasopharynx. Approximately 
37% of these animals developed AOM and 
scanning electron microscopy (SEM) imag-
ing identified robust biofilms in the naso-
pharynx, eustachian tube, and ME mucosa 
of these infected animals (6).
In regard to CRS, the chronic and medi-
cally refractive nature of the disease lends 
itself naturally to a biofilm model. Both 
human and rabbit models of sinusitis have 
repeatedly demonstrated the capability of 
infectious agents to form biofilms. In a 
critical study, Ramadan et al. analyzed tis-
sue samples from patients with CRS under 
SEM and successfully showed that every 
sample had biofilms present in various 
phases of proliferation (7). Further stud-
ies confirmed that the three most com-
mon causative bacterial agents readily 
formed biofilms in respiratory epithelium 
of patients with CRS.
future challenges
•	 Development	 of	 non-invasive	 ima-
ging techniques like optical coherence 
tomography and high frequency ultra-
sound to identify biofilms inside the 
human body (8, 9).
•	 Characterizing	the	role	of	host	surface	
receptors in allowing initial attachment 
of biofilm forming pathogens.
•	 Defining	 the	 role	 of	 viral	 co-infection	
in altering respiratory epithelial surface 
to allow attachment and development 
of biofilms.
•	 Studying	 the	 role	 of	 host	 immune	
response to the formation of biofilms.
•	 Elucidating	 the	 environmental	 factors	
that favor development and/or degra-
dation of biofilms. Recent studies have 
alluded to certain EPS lyases that are 
produced in response to specific envi-
ronmental triggers such as oxygen 
depletion and can enzymatically 
degrade the EPS matrix releasing the 
cells from the biofilm (10).
aIrway reconstructIon utIlIzIng 
tIssue engIneerIng technIques
Tissue engineering is an interdisciplinary 
field where engineering and life science 
intersect with the hope of creating a bio-
logical substitute for human organs and 
tissues. Although airway reconstructive 
surgery arose in the late twentieth century, 
the rapid development and complexity of 
bioengineering and tissue regeneration has 
significantly shaped the current approach to 
airway reconstruction today.
Surgical management of long-segment 
tracheal stenosis in children by its very 
nature is very complex and challenging 
and has been evolving over the last two 
decades with patch (graft) tracheoplasty 
and slide tracheoplasty as the most com-
mon surgical techniques. Although the 
tissue grafts employed in patch tracheo-
plasty re-epithelialize rapidly, the eventual 
outcome of the surgery can be complicated 
by restenosis arising from granulation or 
shrinkage of the graft thus requiring re-
intervention. However, the experience 
with this technique has been reported in 
literature with  varying degrees of success 
(11, 12). Fanous et al. reported successful 
long term outcomes for pericardial tracheo-
plasty performed on 26 patients with long-
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•	 Tissue-engineered	 construct	 for	 long-
segment tracheal stenosis
•	 Utility	 of	 augmented	 cadaveric	 frag-
ment in tracheal reconstruction
mInImally InvasIve technIques 
and roBotIc surgery
Numerous fields have begun to embrace 
minimally invasive surgical approaches. 
These include laparoscopic surgery, endo-
scopic surgery approach for neurosurgi-
cal procedures, endoscopic management 
of mediastinal lesions to name a few. The 
advantages of minimally invasive procedures 
include decreased cosmetic scars, less dissec-
tion, and decreased morbidity. In addition to 
endoscopic procedures, robotic procedures 
offer many of the same advantages (31). 
Some recent areas of investigation include 
robotic assisted airway surgery, endoscopic 
airway surgery, endoscopic and robotic 
assisted thyroid surgery, and the poten-
tial for sentinel lymph nodes biopsy (32). 
Current applications in pediatric otolar-
yngology include endoscopic approach for 
juvenile nasal angiofibromas and endoscopic 
approaches for skull base tumors in children 
(33). In addition, other areas of investiga-
tion include robotic assisted tympanomas-
toid surgery and image guidance endoscopic 
management of congenital problems includ-
ing choanal atresia and canal atresia.
future challenges
•	 Develop	smaller	instruments	and	novel	
approaches for endoscopic robotic assi-
sted airway surgery
•	 Develop	novel	techniques	for	endosco-
pic neck biopsies and management of 
congenital neck mass
•	 Develop	 a	wider	 array	 of	 instruments	
and novel approaches for image guided 
endoscopic choanal atresia surgery
•	 Utilize	 robotic	 approach	 and	 image	
guidance for pediatric mastoid surgery 
and cochlear implant surgery
molecular BIology of audItory 
regeneratIon In snhl
Loss of inner ear (IE) functionality and bal-
ance disorders due to hair cell damage can 
occur through ototoxic, acoustic, environ-
mental, or chemical damage as well as aging 
or genetic conditions. Restoration of IE 
functionality through hair cell  regeneration 
was not even considered a possibility until 
the discovery of hair cell regeneration in 
synthetic scaffold consisting of Marlex mesh 
tube covered in a collagen sponge made 
from porcine dermal collagen as a tracheal 
implant, which was unsuccessful (26). The 
major limitation of acellular scaffolding 
implants is the potential for incomplete 
re-epithelialization, which may lead to bio-
film formation, granulation tissue growth, 
or airway stenosis from cicatricial scar 
formation (27). Similarly, an animal study 
by Weidenbacher et al. demonstrated that 
when using a neo-tracheal tubular implant, 
all animals eventually developed cicatricial 
scar formation and had to be sacrificed (28). 
Therefore, the importance of epithelializa-
tion was confirmed, and research shifted 
toward tissue-engineered implants.
Tissue engineering involves the implan-
tation of stem-cells onto bioscaffolding 
matrices. In these tissue models, function-
ality and epithelialization are aided through 
the use of stem-cells, which are believed to 
hasten the successful incorporation of such 
implants. While some studies have demon-
strated the capability to seed mesenchymal 
stem-cells onto bioscaffolds to produce 
viable cardiac myocyte regeneration, the 
harvest and proliferation of human res-
piratory epithelial cells has proved more 
challenging (29). Currently, there is still 
no widely accepted seeding method for 
these cells (25). In addition to lacking a 
reliable source for respiratory stem-cells, 
further challenge rests in the structure of 
the human trachea itself. Between the epi-
thelial and cartilaginous layers is a submu-
cosal layer that is filled with a dense capillary 
network (30). Some scientists, such as Tan 
et al., hypothesize that it is the incapability 
of the implant to simulate this permeable 
quality that leads to such poor rates of suc-
cessful allograft implantation. Others argue 
that epithelialization of the implant is key to 
successful implantation. Likely, it is a com-
bination of these factors, as well as addi-
tional factors that have not been uncovered, 
which would ultimately lead to improved 
tissue-engineered tracheal implantation. 
In this way, the tissue-engineered trachea 
is still far away from clinical application. 
However, it remains a topic of interest due 
to its vast potential if such an implant is able 
to be designed.
future challenges
•	 Tissue-engineered	construct	 for	 laryn-
gotracheal reconstruction
segment tracheal stenosis with five hospital 
deaths, none from airway obstruction, and 
two re-interventions (13). More recently, 
slide tracheoplasty with cardiopulmonary 
bypass support has shown encouraging 
short-term outcomes with early extuba-
tion post-op and shorter hospital stays for 
patients. Several authors have reported suc-
cessful outcomes for long-segment stenosis 
using this technique with lower mortality 
rates ranging from 10 to 30%, fewer post-
op complications and re-interventions as 
compared to other techniques (14–21). As 
with patch tracheoplasty, varying degrees of 
success have been reported with slide tra-
cheoplasty with Manning et al. demonstrat-
ing lower rates of complications contrasting 
with the less encouraging experience of 
Wright et al. (22, 23).
Owing to the complexity of airway sur-
gical management in children and varying 
degrees of successes with the current surgical 
techniques, the quest for the development 
of a novel allograft or biological implant 
for airway reconstruction is only logical. 
There are several limitations to creating 
novel implants in the airway reconstruc-
tive setting. These include life-threatening 
complications, small sample sizes, and a lack 
of human subjects due to the precarious 
nature of airway surgery. Such complica-
tions, including migration, dislodgement, 
infection, obstruction, adjacent site steno-
sis or granulation, and necrosis, have the 
potential for significant host morbidity and/
or mortality. In this way, the development 
of such an implant has been exceedingly 
difficult. For this reason, no clinically con-
vincing tracheal replacement method or 
implant currently exists.
Belsey described the theoretical tracheal 
implant in the 1950s as a laterally rigid but 
longitudinally flexible, biocompatible, 
non-immunogenic, bacterial resistant, 
airtight stent that promotes respiratory 
epithelialization (24). Early scientists were 
thus disillusioned when they believed the 
implant to be as simple as developing a 
tubular cartilaginous structure. Later, ani-
mal models confirmed the importance of 
respiratory epithelialization in preventing 
granulomatous tissue formation and pro-
moting cilia formation for functionality 
(25). Initial research efforts were largely 
tissue scaffolds aimed at guiding innate 
tissues for quicker regeneration. Shimizu 
and his colleagues were the first to use a 
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have been briefly discussed in this article. 
However, as outlined above, there are some 
great challenges ahead of us and it’s impera-
tive that we ride on our recent success and 
look to extend the current boundaries. With 
science and medicine becoming more and 
more interdisciplinary, we are poised to 
make rapid advances and are placed in an 
excellent position to overcome current chal-
lenges and discover new ones.
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